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We investigate the problems of multiclass cancer classiﬁcation with gene selection from gene expression data. Two diﬀerent con-
structed multiclass classiﬁers with gene selection are proposed, which are fuzzy support vector machine (FSVM) with gene selection
and binary classiﬁcation tree based on SVM with gene selection. Using F test and recursive feature elimination based on SVM as
gene selection methods, binary classiﬁcation tree based on SVM with F test, binary classiﬁcation tree based on SVM with recursive
feature elimination based on SVM, and FSVM with recursive feature elimination based on SVM are tested in our experiments. To
accelerate computation, preselecting the strongest genes is also used. The proposed techniques are applied to analyze breast cancer
data, small round blue-cell tumors, and acute leukemia data. Compared to existing multiclass cancer classiﬁers and binary classiﬁ-
cation tree based on SVM with F test or binary classiﬁcation tree based on SVM with recursive feature elimination based on SVM
mentioned in this paper, FSVM based on recursive feature elimination based on SVM can ﬁnd most important genes that aﬀect
certain types of cancer with high recognition accuracy.
INTRODUCTION
By comparing gene expressions in normal and dis-
easedcells,microarraysareusedtoidentifydiseasedgenes
and targets for therapeutic drugs. However, the huge
amount of data provided by cDNA microarray measure-
ments must be explored in order to answer fundamen-
tal questions about gene functions and their interdepen-
dence [1], and hopefully to provide answers to questions
like what is the type of the disease aﬀecting the cells or
which genes have strong inﬂuence on this disease. Ques-
tions like this lead to the study of gene classiﬁcation prob-
lems.
Many factors may aﬀect the results of the analysis.
One of them is the huge number of genes included in the
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original dataset. Key issues that need to be addressed un-
der such circumstances are the eﬃcient selection of good
predictive gene groups from datasets that are inherently
noisy, and the development of new methodologies that
can enhance the successful classiﬁcation of these complex
datasets.
For multiclass cancer classiﬁcation and discovery, the
performance of diﬀerent discrimination methods includ-
ing nearest-neighbor classiﬁers, linear discriminant anal-
ysis, classiﬁcation trees, and bagging and boosting learn-
ing methods are compared in [2]. Moreover, this prob-
lem has been studied by using partial least squares [3],
Bayesian probit regression [4], and iterative classiﬁcation
trees [5]. But multiclass cancer classiﬁcation, combined
with gene selection, has not been investigated intensively.
In the process of multiclass classiﬁcation with gene selec-
tion, where there is an operation of classiﬁcation, there is
an operation of gene selection, which is the focus in this
paper.
In the past decade, a number of variable (or gene)
selection methods used in two-class classiﬁcation have
been proposed, notably, the support vector machine
(SVM) method [6], perceptron method [7], mutual-
information-based selection method [8], Bayesian vari-
able selection [2, 9, 10, 11, 12], minimum description2005:2 (2005) Multiclass Cancer Classiﬁcation With Gene Selection 161
length principle for model selection [13], voting tech-
nique [14], and so on. In [6], gene selection using re-
cursive feature elimination based on SVM (SVM-RFE)
is proposed. When used in two-class circumstances, it
is demonstrated experimentally that the genes selected
by these techniques yield better classiﬁcation perfor-
mance and are biologically relevant to cancer than the
other methods mentioned in [6], such as feature rank-
ing with correlation coeﬃcients or sensitivity analysis.
But its application in multiclass gene selection has not
been seen for its expensive calculation burden. Thus,
gene preselection is adopted to get over this shortcom-
ing; SVM-RFE is a key gene selection method used in our
study.
As a two-class classiﬁcation method, SVMs’ remark-
able robust performance with respect to sparse and noisy
data makes them ﬁrst choice in a number of applications.
Its application in cancer diagnosis using gene proﬁles is
referred to in [15, 16]. In the recent years, the binary SVM
has been used as a component in many multiclass classi-
ﬁcation algorithms, such as binary classiﬁcation tree and
fuzzy SVM (FSVM). Certainly, these multiclass classiﬁca-
tion methods all have excellent performance, which bene-
ﬁt from their root in binary SVM and their own construc-
tions. Accordingly, we propose two diﬀerent constructed
multiclass classiﬁers with gene selection: one is to use bi-
nary classiﬁcation tree based on SVM (BCT-SVM) with
gene selection while the other is FSVM with gene selec-
tion. In this paper, F test and SVM-RFE are used as our
gene selection methods. Three groups of experiments are
done, respectively, by using FSVM with SVM-RFE, BCT-
SVM with SVM-RFE, and BCT-SVM with F test. Com-
pared to the methods in [2, 3, 5], our proposed methods
can ﬁnd out which genes are the most important genes to
aﬀect certain types of cancer. In these experiments, with
most of the strongest genes selected, the prediction error
rate of our algorithms is extremely low, and FSVM with
SVM-RFE shows the best performance of all.
The paper is organized as follows. Problem statement
is given in “problem statement.” BCT-SVM with gene se-
lection is outlined in “binary classiﬁcation tree based on
SVM with gene” selection. FSVM with gene selection is
described in “FSVM with gene selection.” Experimental
results on breast cancer data, small round blue-cell tu-
mors data, and acute leukemia data are reported in “ex-
perimental results.” Analysis and discussion are presented
in “analysis and discussion.” “Conclusion” concludes the
paper.
PROBLEM STATEMENT
Assume there are K classes of cancers. Let w =
[w1,...,w m]d e n o t et h ec l a s sl a b e l so fm samples, where
wi = k indicates the sample i being cancer k,w h e r e
k = 1,...,K. Assume x1,...,x n are n genes. Let xij be the
measurement of the expression level of the jth gene for
the ith sample, where j = 1,2,...,n, X = [xij]m,n,d e n o t e s
the expression levels of all genes, that is,
X =

       
Gene 1 Gene 2 ··· Gene n
x11 x12 ··· x1n
x12 x22 ··· x2n
. . .
. . .
...
. . .
xm1 xm2 ··· xmn

       
. (1)
In the two proposed methods, every sample is parti-
tionedbyaseriesofoptimalhyperplanes.Theoptimalhy-
perplane means training data is maximally distant from
the hyperplane itself, and the lowest classiﬁcation error
rate will be achieved when using this hyperplane to clas-
sify current training set. These hyperplanes can be mod-
eled as
ωstXT
i +bst = 0( 2 )
and the classiﬁcation functions are deﬁned as fst(XT
i ) =
ωstXT
i + bst,w h e r eXi denotes the ith row of matrix X; s
and t mean two partitions which are separated by an opti-
mal hyperplane, and what these partitions mean lies on
the construction of multiclass classiﬁcation algorithms;
for example, if we use binary classiﬁcation tree, s and t
meantwohalvesseparatedinaninternalnode,whichmay
be the root node or a common internal node; if we use
FSVM, s and t mean two arbitrary classes in K classes. ωst
is an n-dimensional weight vector; bst is a bias term.
SVM algorithm is used to determinate these optimal
hyperplanes. SVM is a learning algorithm originally in-
troduced by Vapnik [17, 18] and successively extended by
many other researchers. SVMs can work in combination
with the technique of “kernels” that automatically do a
nonlinear mapping to a feature space so that SVM can
settle the nonlinear separation problems. In SVM, a con-
vexquadraticprogrammingproblemissolvedand,ﬁnally,
optimal solutions of ωst and bst are given. Detailed solu-
tion procedures are found in [17, 18].
Along with each binary classiﬁcation using SVM, one
operation of gene selection is done in advance. Speciﬁc
gene selection methods used in our paper are described
brieﬂy in “experimental results.” Here, gene selection is
done before SVM trained means that when an SVM is
trained or used for prediction, dimensionality reduction
will be done on input data, Xi, referred to as the strongest
genesselected.WeusefunctionYi = I(βstXT
i )tor epr esent
this procedure, where βst is an n×n matrix, in which only
diagonal elements may be equal to 1 or 0; and all other el-
ementsareequalto0;genescorrespondingtothenonzero
diagonal elements are important. βst is gotten by speciﬁc
gene selection methods; function I(·) means to select all
nonzero elements in the input vector to construct a new
vector , for example, I([102])T = [12T]. So (2)i sr e w r i t -
ten as
βstXT
i +bst = 0, Yi = I
 
βstXT
i
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and the classiﬁcation functions are rewritten as fst(XT
i ) =
βstXT
i +bst accordingly.
In order to accelerate calculation rate, preselect-
ing genes before the training of multiclass classiﬁers is
adopted. Based on all above, we propose two diﬀerent
constructed multiclass classiﬁers with gene selection: (1)
binary classiﬁcation tree based on SVM with gene selec-
tion, and (2) FSVM with gene selection.
BINARY CLASSIFICATION TREE BASED ON SVM
WITH GENE SELECTION
Binary classiﬁcation tree is an important class of
machine-learning algorithms for multiclass classiﬁcation.
We construct binary classiﬁcation tree with SVM; for
short, we call it BCT-SVM. In BCT-SVM, there are K − 1
internal nodes and K terminal nodes. When building the
tree, the solution of (3) is searched by SVM at each in-
ternal node to separate the data in the current node into
the left children node and right children node with ap-
pointed gene selection method, which is mentioned in
“experimental results”. Which class or classes should be
partitionedintotheleft(orright)childrennodeisdecided
at eachinternal node byimpurity reduction [19],whichis
used to ﬁnd the optimal construction of the classiﬁer. The
partition scheme with largest impurity reduction (IR) is
optimal. Here, we use Gini index as our IR measurement
criterion, which is also used in classiﬁcation and regres-
sion trees (CARTs) [20] as a measurement of class diver-
sity. Denote as M the training dataset at the current node,
as ML and MR the training datasets at the left and right
children nodes, as Mi sample set of class i in the training
set, as MR·i and ML·i sample sets of class i of the training
dataset at the left and right children nodes; and we use λΘ
to denote the number of samples in dataset Θ; the cur-
rent IR can be calculated as follows, in which c means the
number of classes in the current node:
IR(M) =
1
λMλML
c  
i=1
 
λML·i
 2 +
1
λMλMR
c  
i=1
 
λMR·i
 2
−
1
λM
2
c  
i=1
 
λMi
 2.
(4)
When the maximum of IR(M) is found out based on
all potential combinations of classes in the current
internal node, which part of data should be partitioned
into the left children node is decided. For the details to
construct the standard binary decision tree, we refer to
[19, 20].
After this problem is solved, samples partitioned into
the left children node are labeled with −1, and the oth-
ers are labeled with 1, based on these measures, a binary
SVMclassiﬁerwithgeneselectionistrainedusingthedata
of the two current children nodes. As to gene selection,
it is necessary because the cancer classiﬁcation is a typ-
ical problem with small sample and large variables, and
it will cause overﬁtting if we directly train the classiﬁer
with all genes; here, all gene selection methods based on
two-class classﬁcation could be used to construct βst in
(3). The process of building a whole tree is recursive, as
seen in Figure 1.
When the training data at a node cannot be split any
further, that node is identiﬁed as a terminal node and
what we get from decision function corresponds to the la-
bel for a particular class. Once the tree is built, we could
predict the results of the samples with genes selected by
this tree; trained SVM will bring them to a terminal node,
which has its own label. In the process of building BCT-
SVM, there are K − 1 operations of gene selection done.
This is due to the construction of BCT-SVM, in which
there are K −1S V M s .
FSVM WITH GENE SELECTION
OtherthanBCT-SVM,FSVMhasapairwiseconstruc-
tion, which means every hyperplane between two arbi-
trary classes should be searched using SVM with gene se-
lection. These processes are modeled by (3).
FSVM is a new method ﬁrstly proposed by Abe and
Inoue in [21, 22]. It was proposed to deal with unclassi-
ﬁable regions when using one versus the rest or pairwise
classiﬁcation method based on binary SVM for n(> 2)-
class problems. FSVM is an improved pairwise classiﬁ-
cation method with SVM; a fuzzy membership function
is introduced into the decision function based on pair-
wise classiﬁcation. For the data in the classiﬁable regions,
FSVM gives out the same classiﬁcation results as pair-
wise classiﬁcation with SVM method and for the data in
the unclassiﬁable regions, FSVM generates better classi-
ﬁcation results than the pairwise classiﬁcation with SVM
method.Intheprocessofbeingtrained,FSVMisthesame
as the pairwise classiﬁcation method with SVM that is re-
ferred to in [23].
I no r d e rt od e s c r i b eo u rp r o p o s e da l g o r i t h mc l e a r l y ,
we denote four input variables: the sample matrix X0 =
{x1,x2,...,xk,...,xm}T, that is, X0 is a matrix composed
ofsomecolumnsoforiginaltrainingdatasetX,whichcor -
responds to preselected important genes; the class-label
vector y ={y1,y 2,...,y k,...,y m}T; the number of classes
in training set ν; and the number of important genes used
in gene selection κ. With these four input variables, the
training process of FSVM with gene selection is expressed
in (Algorithm 1).
In Algorithm 1, υ = GeneSelection(µ,φ,κ)i sr e a l -
ization of a speciﬁc binary gene selection algorithm, υ
denotes the genes important for two speciﬁc draw-out
classes and is used to constructβst in (3), SV MTrain(·)i s
realization of binary SVM algorithm, α is a Lagrangemul-
tiplier vector, and  is a bias term. γ, alpha,a n dbias are
the output matrixes. γ is made up of all important genes
selected, in which each row corresponds to a list of im-
portant genes selected between two speciﬁc classes. alpha
is a matrix with each row corresponding to Lagrange2005:2 (2005) Multiclass Cancer Classiﬁcation With Gene Selection 163
Build tree
Training data for the current node
Single class?
Yes Left node
(terminal node)
Class label for
the left node
No
Find a binary classiﬁcation scheme
by maximum impurity
reduction (IR)
Feature (or gene) selection
Find an optimal hyperplane
with SVM using features
(or genes) selected
Split the current node
Build left subtree Build right subtree
Figure 1. Binary classiﬁcation tree based on SVM with gene selection.
multiplier vector by an SVM classiﬁer trained between
two speciﬁc classes, and bias is the vector made up of bias
terms of these SVM classiﬁers.
In this process, we may see there areK(K −1)/2S V M s
trained and K(K − 1)/2 gene selections executed. This
means that many important genes relative to two speciﬁc
classes of samples will be selected.
Based on the K(K −1)/2 optimal hyperplanes and the
strongest genes selected, decision function is constructed
based on (3). Deﬁne fst(Xi) =−fts(Xi),(s  = t); the fuzzy
membership function mst(Xi) is introduced on the direc-
tions orthogonal to fst(Xi) = 0a s
mst
 
Xi
 
=



1f o r fst
 
Xi
 
≥ 1,
fst
 
Xi
 
otherwise.
(5)
Using mst(Xi)(s  = t, s = 1,...,n), the class i
membership function of Xi is deﬁned as ms(Xi) =
mint=1,...,nmst(Xi), which is equivalent to ms(Xi) =
min(1,mins =t,t=1,...,n fst(Xi)); now an unknown sample Xi
is classiﬁed by argmaxs=1,...,nms(Xi).
EXPERIMENTAL RESULTS
F test and SVM-RFE are gene selection methods
used in our experiments. In F test, the ratio R(j) =
 m
i=1(
 K
k=11Ωi=k)(xkj − xj)2/
 m
i=1(
 K
k=1 1Ωi=k)(xij −
xkj)2,1 ≤ j ≤ n, is used to select genes, in which xj
denotes the average expression level of gene j across all
samples and xkj denotes the average expression level of
gene j across the samples belonging to class k where class
k corresponds to {Ωi = k}; and the indicator function
1Ω is equal to one if event Ω is true and zero otherwise.
Genes with bigger R(j) are selected. From the expression
of R(j) , it can be seen F test could select genes among
l(> 3) classes [14]. As to SVM-RFE, it is recursive feature
elimination based on SVM. It is a circulation procedure
for eliminating features combined with training an SVM
classiﬁer and, for each elimination operation, it consists
of three steps: (1) train the SVM classiﬁer, (2) compute
the ranking criteria for all features, and (3) remove the
feature with the smallest ranking scores, in which all
ranking criteria are relative to the decision function
of SVM. As a linear kernel SVM is used as a classiﬁer164 Yong Mao et al 2005:2 (2005)
Inputs:
Sample matrix X0 ={ x1,x2,...,xk,...,xm}T, class-label vector y ={y1,y 2,...,y k,...,y m}T,
number of classes in training set ν = K, and number of important genes we need κ = z
Initialize:
Set γ, alpha,a n dbias as empty matrixes. γ will be used to contain index number of ranked features;
alpha and bias will be used to contain parameters of FSVM
Training:
for i ∈{ 1,...,ν −1}
for j ∈{ i −1,...,ν}
Initialize µ as an empty matrix for containing draw-out samples and φ as an empty vector for contain-
ing new-built class labels of class i and class j
for k ∈{ 1,...,m}
if yk = iorj
Add X0’ ykth row to µ as µ’s last row
if yk = i, add element -1 to φ as φ’s last element
else, add element 1 to φ as φ’s last element
end
end
Gene selection
Initialize υ as an empty vector for containing important gene index number
Get important genes between class i and class j
υ = GeneSelection(µ,φ,κ)
Put the results of gene selection into ranked feature matrix
Add υ to γ as γ’s last row
Train binary SVM using the row of genes selected right now
Initialize τ as an empty matrix for containing training data corresponding to the genes selected;
Build the new matrix; Copy every column of µ that υ indicates into τ as its column; Train the
classiﬁer
{α }=SVMTrain(τ, φ)
Add αT to alpha as alpha’s last row
Add  to bias as bias’s last element
end
end
Outputs:
Ranked feature matrix γ
Two parameter matrixes of FSVM, alpha and bias
Algorithm 1. The FSVM with gene selection training algorithm.
between two speciﬁc classes s and t, the square of every
element of weight vector ωst in (2) is used as a score to
evaluate the contribution of the corresponding genes.
The genes with the smallest scores are eliminated. Details
are referred to in [6]. To speed up the calculation, gene
preselection is generally used. On every dataset we use
the ﬁrst important 200 genes are selected by F test before
multiclass classiﬁers with gene selection are trained. Note
that F test requires normality of the data to be eﬃcient
which is not always the case for gene expression data.
That is the exact reason why we cannot only use F test
to select genes. Since the P values of important genes are
relatively low, that means the F test scores of important
genes should be relatively high. Considering that the
number of important genes is often among tens of genes,
we preselect the number of genes as 200 according to our2005:2 (2005) Multiclass Cancer Classiﬁcation With Gene Selection 165
experience in order to avoid losing some important genes.
In the next experiments, we will show this procedure
works eﬀectively.
Combining these two speciﬁc gene selection meth-
ods with the multiclass classiﬁcation methods, we pro-
posethreealgorithms:(1)BCT-SVMwithFtest,(2)BCT-
SVM with SVM-RFE, and (3) FSVM with SVM-RFE. As
mentioned in [4, 9], every algorithm is tested with cross-
validation (leave-one-out) method based on top 5, top
10, and top 20 genes selected by their own gene selection
methods.
Breastcancerdataset
In our ﬁrst experiment, we will focus on hereditary
breast cancer data, which can be downloaded from the
web page for the original paper [24]. In [24], cDNA mi-
croarrays are used in conjunction with classiﬁcation algo-
rithmstoshowthefeasibilityofusingdiﬀerencesinglobal
gene expression proﬁles to separate BRCA1 and BRCA2
mutation-positive breast cancers. Twenty-two breast tu-
mor samples from 21 patients were examined: 7 BRCA1,
8 BRCA2, and 7 sporadic. There are 3226 genes for each
tumor sample. We use our methods to classify BRCA1,
BRCA2, and sporadic. The ratio data is truncated from
below at 0.1 and above at 20.
Table 1 lists the top 20 strongest genes selected by us-
ing our methods. (For reading purpose, sometimes in-
stead of clone ID, we use the gene index number in the
database [24].) The clone ID and the gene description of
a typical column of the top 20 genes selected by SVM-
RFE are listed in Table 2; more information about all se-
lected genes corresponding to the list in Table 1 could be
found at http://www.sensornet.cn/fxia/top 20 genes.zip.
It is seen that gene 1008 (keratin 8) is selected by all the
three methods. This gene is also an important gene listed
in [4, 7, 9]. Keratin 8 is a member of the cytokeratin fam-
ily of genes. Cytokeratins are frequently used to identify
breast cancer metastases by immunohistochemistry [24].
Gene 10 (phosphofructokinase, platelet) and gene 336
(transducer of ERBB2, 1) are also important genes listed
in [7]. Gene 336 is selected by FSVM with SVM-RFE and
BCT-SVM with SVM-RFE; gene 10 is selected by FSVM
with SVM-RFE.
Using the top 5, 10, and 20 genes each for these three
methods, the recognition accuracy is shown in Table 3.
When using top 5 genes for classiﬁcation, there is one er-
ror for BCT-SVM with F test and no error for the other
two methods. When using top 10 and 20 genes, there is
no error for all the three methods. Note that the perfor-
mance of our methods is similar to that in [4], where the
authors diagnosed the tumor types by using multinomial
probit regression model with Bayesian gene selection. Us-
ing top 10 genes, they also got zero misclassiﬁcation.
Smallroundblue-celltumors
In this experiment, we consider the small round
blue-cell tumors (SRBCTs) of childhood, which include
neuroblastoma (NB), rhabdomyosarcoma (RMS), non-
Hodgkin lymphoma (NHL), and the Ewing sarcoma
(EWS) in [25]. The dataset of the four cancers is com-
posed of 2308 genes and 63 samples, where the NB has
12 samples; the RMS has 23 samples; the NHL has 8 sam-
ples, and the EMS has 20 samples. We use our methods to
classify the four cancers. The ratio data is truncated from
below at 0.01.
Table 4 lists the top 20 strongest genes selected by us-
ing our methods. The clone ID and the gene description
of a typical column of the top 20 genes selected by SVM-
RFE are listed in Table 5; more information about all se-
lected genes corresponding to the list in Table 4 could be
found at http://www.sensornet.cn/fxia/top 20 genes.zip.
It is seen that gene 244 (clone ID 377461), gene 2050
(clone ID 295985), and gene 1389 (clone ID 770394) are
selected by all the three methods, and these genes are
also important genes listed in [25]. Gene 255 (clone ID
325182), gene 107 (clone ID 365826), and gene 1 (clone
ID 21652, (catenin alpha 1)) selected by BCT-SVM with
SVM-RFE and FSVM with SVM-RFE are also listed in
[25] as important genes.
Using the top 5, 10, and 20 genesforthese threemeth-
ods each, the recognition accuracy is shown in Table 6.
When using top 5 genes for classiﬁcation, there is one er-
ror for BCT-SVM with F test and no error for the other
two methods. When using top 10 and 20 genes, there is
no error for all the three methods.
In [26], Yeo et al applied k nearest neighbor (kNN),
weighted voting, and linear SVM in one-versus-rest
fashion to this four-class problem and compared the per-
formances of these methods when they are combined
with several feature selection methods for each binary
classiﬁcation problem. Using top 5 genes, top 10 genes,
or top 20 genes, kNN, weighted voting, or SVM com-
bined with all the three feature selection methods, re-
spectively, without rejection all have errors greater than
or equal to 2. In [27], Lee et al used multicategory
SVM with gene selection. Using top 20 genes, their
recognition accuracy is also zero misclassiﬁcation num-
ber.
Acuteleukemiadata
We have also applied the proposed methods to the
leukemia data of [14] ,w h i c hi sa v a i l a b l ea thttp://www.
sensornet.cn/fxia/top 20 genes.zip. The microarray data
contains 7129 human genes, sampled from 72 cases of
cancer, of which 38 are of type B cell ALL, 9 are of type T
cell ALL, and 25 of type AML. The data is preprocessed as
recommended in [2]: gene values are truncated from be-
low at 100 and from above at 16000; genes having the ra-
tio of the maximum over the minimum less than 5 or the
diﬀerence between the maximum and the minimum less
than 500 are excluded; and ﬁnally the base-10 logarithm
is applied to the 3571 remaining genes. Here we study the
38 samples in training set, which is composed of 19 B-cell
ALL, 8 T-cell ALL, and 11 AML.166 Yong Mao et al 2005:2 (2005)
Table 1. The index no of the strongest genes selected in hereditary breast cancer dataset.
No
FSVM with BCT-SVM with BCT-SVM with
SVM-RFE F test SVM-RFE
1231212
1 1008 1859 422 501 1148 750 1999
2 955 1008 2886 2984 838 860 3009
3 1479 10 343 3104 1859 1008 158
4 2870 336 501 422 272 422 2761
5 538 158 92 2977 1008 2804 247
6 336 1999 3004 2578 1179 1836 1859
7 3154 247 1709 3010 1065 3004 1148
8 2259 1446 750 2804 2423 420 838
9 739 739 2299 335 1999 1709 1628
10 2893 1200 341 2456 2699 3065 1068
11 816 2886 1836 1116 1277 2977 819
12 2804 2761 219 268 1068 585 1797
13 1503 1658 156 750 963 1475 336
14 585 560 2867 2294 158 3217 2893
15 1620 838 3104 156 609 501 2219
16 1815 2300 1412 2299 1417 146 585
17 3065 538 3217 2715 1190 343 1008
18 3155 498 2977 2753 2219 1417 2886
19 1288 809 1612 2979 560 2299 36
20 2342 1092 2804 2428 247 2294 1446
Table 2. A part of the strongest genes selected in hereditary breast cancer dataset (the ﬁrst row of genes in Table 1).
Rank Index no Clone ID Gene description
1 1008 897781 Keratin 8
2 955 950682 Phosphofructokinase, platelet
3 1479 841641 Cyclin D1 (PRAD1: parathyroid adenomatosis 1)
4 2870 82991
Phosphodiesterase I/nucleotide pyrophosphatase 1
(homologous to mouse Ly-41 antigen)
5 538 563598 Human GABA-A receptor π subunit mRNA, complete cds
6 336 823940 Transducer of ERBB2, 1
7 3154 135118 GATA-binding protein 3
8 2259 814270 Polymyositis/scleroderma autoantigen 1 (75kd)
9 739 214068 GATA-binding protein 3
10 2893 32790 mutS (Ec o l i ) homolog 2 (colon cancer, nonpolyposis type 1)
11 816 123926 Cathepsin K (pycnodysostosis)
12 2804 51209 Protein phosphatase 1, catalytic subunit, beta isoform
13 1503 838568 Cytochrome c oxidase subunit VIc
14 585 293104 Phytanoyl-CoA hydroxylase (Refsum disease)
15 1620 137638 ESTs
16 1815 141959
Homo sapiens mRNA; cDNA DKFZp566J2446
(from clone DKFZp566J2446)
17 3065 199381 ESTs
18 3155 136769
TATA box binding protein (TBP)-associated factor,
RNA polymerase II, A, 250kd
19 1288 564803 Forkhead (drosophila)-like 16
20 2342 284592 Platelet-derived growth factor receptor, alpha polypeptide2005:2 (2005) Multiclass Cancer Classiﬁcation With Gene Selection 167
Table 3. Classiﬁers’ performance on hereditary breast cancer dataset by cross-validation (number of wrong classiﬁed samples in
leave-one-out test).
Classiﬁcation method Top 5 Top 10 Top 20
FSVM with SVM-RFE 0 0 0
BCT-SVM with F test 1 0 0
BCT-SVM with SVM-RFE 0 0 0
Table 4. The index no of the strongest genes selected in small round blue-cell tumors dataset.
No
FSVM with BCT-SVM with BCT-SVM with
SVM-RFE F test SVM-RFE
123456123123
1 246 255 1954 851 187 1601 1074 169 422 545 174 851
2 1389 867 1708 846 509 842 246 1055 1099 1389 1353 846
3 851 246 1955 1915 2162 1955 1708 338 758 2050 842 1915
4 1750 1389 509 1601 107 255 1389 422 1387 1319 1884 1601
5 107 842 2050 742 758 2046 1954 1738 761 1613 1003 742
6 2198 2050 545 1916 2046 1764 607 1353 123 1003 707 1916
7 2050 365 1389 2144 2198 509 1613 800 84 246 1955 2144
8 2162 742 2046 2198 2022 603 1645 714 1888 867 2046 2198
9 607 107 348 1427 1606 707 1319 758 951 1954 255 1427
10 1980 976 129 1 169 174 566 910 1606 1645 169 1
11 567 1319 566 1066 1 1353 368 2047 1914 1110 819 1066
12 2022 1991 246 867 1915 169 1327 2162 1634 368 509 867
13 1626 819 1207 788 788 1003 244 2227 867 129 166 788
14 1916 251 1003 153 1886 742 545 2049 783 348 1207 153
15 544 236 368 1980 554 2203 1888 1884 2168 365 603 1980
16 1645 1954 1105 2199 1353 107 2050 1955 1601 107 796 2199
17 1427 1708 1158 783 338 719 430 1207 335 1708 1764 783
18 1708 1084 1645 1434 846 166 365 326 1084 187 719 1434
19 2303 566 1319 799 1884 1884 1772 796 836 1626 107 799
20 256 1110 1799 1886 2235 1980 1298 230 849 1772 2203 1886
Table 7 lists the top 20 strongest genes selected by us-
ing our methods. The clone ID and the gene description
of a typical column of the top 20 genes selected by SVM-
RFE are listed in Table 8; more information about all se-
lected genes corresponding to the list in Table 7 could be
found at http://www.sensornet.cn/fxia/top 20 genes.zip.
It is seen that gene 1882 (CST3 cystatin C (amyloid an-
giopathy and cerebral hemorrhage)), gene 4847 (zyxin),
and gene 4342 (TCF7 transcription factor 7 (T cell spe-
ciﬁc)) are selected by all the three methods. In the three
genes, the ﬁrst two are the most important genes listed in
many literatures. Gene 2288 (DF D component of com-
plement (adipsin)) is another important gene having bio-
logicalsigniﬁcance,whichisselectedbyFSVMwithSVM-
RFE.
Using thetop 5, 10, and 20 genesforthese threemeth-
ods each, the recognition accuracy is shown in Table 9.
When using top 5 genes for classiﬁcation, there is one er-
ror for FSVM with SVM-RFE, two errors for BCT-SVM
with SVM-RFE and BCT-SVM with F test, respectively.
When using top 10 genes for classiﬁcation, there is no er-
ror for FSVM with SVM-RFE, two errors for BCT-SVM
with SVM-RFE and four errors for BCT-SVM with F test.
When using top 20 genes for classiﬁcation, there is one er-
ror for FSVM with SVM-RFE, two errors for BCT-SVM
with SVM-RFE and two errors for BCT-SVM with F test.
Again note that the performance of our methods is simi-
lar to that in [4], where the authors diagnosed the tumor
types by using multinomial probit regression model with
Bayesian gene selection. Using top 10 genes, they also got
zero misclassiﬁcation.
ANALYSIS AND DISCUSSION
According to Tables 1–9, there are many important
genes selected by these three multiclass classiﬁcation algo-
rithms with gene selection. Based on these selected genes,
the prediction error rate of these three algorithms is low.168 Yong Mao et al 2005:2 (2005)
Table 5. A part of the strongest genes selected in small round blue-cell tumors dataset (the ﬁrst row of genes in Table 4).
Rank Index no Clone ID Gene description
1 246 377461 Caveolin 1, caveolae protein, 22kd
2 1389 770394 Fc fragment of IgG, receptor, transporter, alpha
3 851 563673 Antiquitin 1
4 1750 233721 Insulin-like growth factor binding protein 2 (36kd)
5 107 365826 Growth arrest-speciﬁc 1
6 2198 212542
H sapiens mRNA; cDNA DKFZp586J2118
(from clone DKFZp586J2118)
7 2050 295985 ESTs
8 2162 308163 ESTs
9 607 811108 Thyroid hormone receptor interactor 6
10 1980 841641 Cyclin D1 (PRAD1: parathyroid adenomatosis 1)
11 567 768370
tissue inhibitor of metalloproteinase 3
(Sorsby fundus dystrophy, pseudoinﬂammatory)
12 2022 204545 ESTs
13 1626 811000
Lectin, galactoside-binding, soluble, 3 binding
protein (galectin 6 binding protein)
14 1916 80109 Major histocompatibility complex, class II, DQ alpha 1
15 544 1416782 Creatine kinase, brain
16 1645 52076 Olfactomedinrelated ER localized protein
17 1427 504791 Glutathione S-transferase A4
18 1708 43733 Glycogenin 2
19 2303 782503 H sapiens clone 23716 mRNA sequence
20 256 154472
Fibroblast growth factor receptor 1
(fms-related tyrosine kinase 2, Pfeiﬀer syndrome)
Table 6. Classiﬁers’ performance on small round blue-cell tumors dataset by cross-validation (number of wrong classiﬁed samples in
leave-one-out test).
Classiﬁcation method Top 5 Top 10 Top 20
FSVM with SVM-RFE 0 0 0
BCT-SVM with F test 1 0 0
BCT-SVM with SVM-RFE 0 0 0
By comparing the results of these three algorithms, we
consider that FSVM with SVM-RFE algorithm generates
thebestresults.BCT-SVMwithSVM-RFEandBCT-SVM
with F test have the same multiclass classiﬁcation struc-
ture. The results of BCT-SVM with SVM-RFE are better
than those of BCT-SVM with F test, because their gene
selection methods are diﬀerent; a better gene selection
method combined with the same multiclass classiﬁcation
method will perform better. It means SVM-RFE is better
than F test combined with multiclass classiﬁcation meth-
ods; the results are similar to what is mentioned in [6], in
which the two gene selection methods are combined with
two-class classiﬁcation methods.
FSVM with SVM-RFE and BCT-SVM with SVM-
RFE have the same gene selection methods. The results
of FSVM with SVM-RFE are better than those of BCT-
SVM with SVM-RFE whether in gene selection or in
recognition accuracy, because the constructions of their
multiclass classiﬁcation methods are diﬀerent, which is
explained in two aspects. (1) The genes selected by FSVM
with SVM-RFE are more than those of BCT-SVM with
SVM-REF. In FSVM there are K(K − 1)/2o p e r a t i o n so f
gene selection, but in BCT-SVM there are only K − 1
operations of gene selection. An operation of gene se-
lection between every two classes is done in FSVM with
SVM-RFE; (2) FSVM is an improved pairwise classiﬁca-
tion method, in which the unclassiﬁable regions being
in BCT-SVM are classiﬁed by FSVM’s fuzzy membership
function [21, 22]. So, FSVM with SVM-RFE is considered
as the best of the three.
CONCLUSION
In this paper, we have studied the problem of mul-
ticlass cancer classiﬁcation with gene selection from
gene expression data. We proposed two diﬀerent new
constructed classiﬁers with gene selection, which are
FSVM with gene selection and BCT-SVM with gene2005:2 (2005) Multiclass Cancer Classiﬁcation With Gene Selection 169
Table 7. The index no of the strongest genes selected in acute leukemia dataset.
No
FSVM with BCT-SVM with BCT-SVM with
SVM-RFE F test SVM-RFE
1231212
1 6696 1882 6606 2335 4342 1882 4342
2 6606 4680 6696 4680 4050 6696 4050
3 4342 6201 4680 2642 1207 5552 5808
4 1694 2288 4342 1882 6510 6378 1106
5 1046 6200 6789 6225 4052 3847 3969
6 1779 760 4318 4318 4055 5300 1046
7 6200 2335 1893 5300 1106 2642 6606
8 6180 758 1694 5554 1268 2402 6696
9 6510 2642 4379 5688 4847 3332 2833
10 1893 2402 2215 758 5543 1685 1268
11 4050 6218 3332 4913 1046 4177 4847
12 4379 6376 3969 4082 2833 6606 6510
13 1268 6308 6510 6573 4357 3969 2215
14 4375 1779 2335 6974 4375 6308 1834
15 4847 6185 6168 6497 6041 760 4535
16 6789 4082 2010 1078 6236 2335 1817
17 2288 6378 1106 2995 6696 2010 4375
18 1106 4847 5300 5442 1630 6573 5039
19 2833 5300 4082 2215 6180 4586 4379
20 6539 1685 1046 4177 4107 2215 5300
Table 8. A part of the strongest genes selected in small round blue-cell tumors dataset (the second row of genes in Table 4).
Rank Index no Gene accession number Gene description
1 1882 M27891 at CST3 cystatin C (amyloid angiopathy and cerebral hemorrhage)
2 4680 X82240 rna1 at
TCL1 gene (T-cell leukemia) extracted from H sapiens
mRNA for T-cell leukemia/lymphoma 1
3 6201 Y00787 s at Interleukin-8 precursor
4 2288 M84526 at DF D component of complement (adipsin)
5 6200 M28130 rna1 s at Interleukin-8 (IL-8) gene
6 760 D88422 at Cystatin A
7 2335 M89957 at IGB immunoglobulin-associated beta (B29)
8 758 D88270 at GB DEF = (lambda) DNA for immunoglobin light chain
9 2642 U05259 rna1 at
MEF2C MADS box transcription enhancer factor 2,
polypeptide C (myocyte enhancer factor 2C)
10 2402 M96326 rna1 at Azurocidin gene
11 6218 M27783 s at ELA2 Elastatse 2, neutrophil
12 6376 M83652 s at PFC properdin P factor, complement
13 6308 M57731 s at GRO2 GRO2 oncogene
14 1779 M19507 at MPO myeloperoxidase
15 6185 X64072 s at SELL leukocyte adhesion protein beta subunit
16 4082 X05908 at ANX1 annexin I (lipocortin I)
17 6378 M83667 rna1 s at NF-IL6-beta protein mRNA
18 4847 X95735 at Zyxin
19 5300 L08895 at
MEF2C MADS box transcription enhancer factor 2,
polypeptide C (myocyte enhancer factor 2C)
20 1685 M11722 at Terminal transferase mRNA170 Yong Mao et al 2005:2 (2005)
Table 9. Classiﬁers’ performance on acute leukemia dataset by cross-validation (number of wrong classiﬁed samples in leave-one-out
test).
Classiﬁcation method Top 5 Top 10 Top 20
FSVM with SVM-RFE 1 0 1
BCT-SVM with F test 2 4 2
BCT-SVM with SVM-RFE 2 1 2
selection. F test and SVM-RFE are used as our gene se-
lection methods combined with multiclass classiﬁcation
methods. In our experiments, three algorithms (FSVM
with SVM-RFE, BCT-SVM with SVM-RFE, and BCT-
SVM with F test) are tested on three datasets (the real
breast cancer data, the small round blue-cell tumors, and
theacuteleukemia data).Theresultsof thesethreegroups
of experiments show that more important genes are se-
lected by FSVM with SVM-RFE, and by these genes se-
lected it shows higher prediction accuracy than the other
two algorithms. Compared to some existing multiclass
cancer classiﬁers with gene selection, FSVM based on
SVM-RFE also performs very well. Finally, an explanation
is provided on the experimental results of this study.
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